DARA BioSciences, Inc. Will Present at NYSSA Investing in Life Sciences Conference, November 29

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it will present at the New York Society of Security Analysts' 16th Annual Investing in Life Sciences conference on Thursday, November 29. DARA recently launched its second product in five months (Soltamox®, the only FDA-approved oral liquid version of tamoxifen citrate), and is planning a third product launch for first quarter of 2013. David J. Drutz, M.D., DARA’s chief executive officer, will present at 10:45am. The conference is being held at The New York Society of Security Analysts in New York City.